15:58 Dec 05

Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1077.00
+9.50 (+0.89%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Jubilant Pharmova Ltd. Financials

Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1077.00
+9.50 (+0.89%)
15:58 Dec 05
Quality
image/svg+xml

82/100
High Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

11

Weakness

3

Opportunity

1

Threats

0

13.41 %

ROE %

6.58 %

ROA %

29.99

EPS

395.88

BVPS

11.60 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
6130.16 6281.73 6702.9 7234.5 7617.6
Operating Expenses +
4973.83 5505.48 5802.1 6060.8 6353.8
Raw Material
1550.32 1918.63 2062.5 2282.4 2449
Increase Decrease in Cost
-62.32 -40.7 78.2 34.6 -33.8
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2043.39 2166.02 2216 2267.9 2378
Miscellaneous Expenses
1845.68 1965.97 1927.8 2070.1 1560.6
Operating Profit
1156.33 776.25 900.8 1173.7 1263.8
Other Income
11.29 38.33 68.7 56.8 42.9
Depreciation
381.7 554.03 381.9 368.6 389.4
Interest
145.49 188.2 272.3 240.3 207.5
Profit before tax and exceptio..
640.43 72.34 315.3 621.6 709.8
Exceptional Items
0 -56.82 -168.9 359.5 -28
PBT
640.43 15.53 146.4 981.1 737.8
Provision for Taxation
217.43 92.66 97.8 144.3 206.8
Net Profit
423 -77.13 48.6 836.8 475
NET Profit after MI
413.94 -60.98 77.1 839.4 477.7
EPS
26 -3.83 4.86 52.99 30.16
Operating Profit Margin (%)
18.86 12.36 13.44 16.22 16.59
Net Profit Margin (%)
6.75 -0.97 1.15 11.6 6.27

Jubilant Pharmova Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 47.70 47.70 50.70 50.70 50.70 50.70
FII 16.60 17.40 17.20 17.00 17.90 19.50
Public 10.50 9.50 7.10 7.00 5.70 4.10
Others 25.20 25.40 25.00 25.30 25.70 25.70
Shareholder Shares Holding %
Download Our App On: